{{unsourced|date=February 2015}}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 379167992
| IUPAC_name = ''N'',''N''-dimethyl-3-[2-(trifluoromethyl)-10''H''-phenothiazin-10-yl]propan-1-amine
| image = Triflupromazine.svg
| width = 222
| image2 = Triflupromazine3d.png

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|CONS|triflupromazine}}
| MedlinePlus = a600010
| pregnancy_category =  
| legal_US = Rx-only
| routes_of_administration =  
<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 146-54-3
| ATC_prefix = N05
| ATC_suffix = AA05
| ATC_supplemental =  
| PubChem = 5568
| IUPHAR_ligand = 4330
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB00508
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 5367
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = RO16TQF95Y
| KEGG_Ref = {{keggcite|changed|kegg}}
| KEGG = D00390
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 570
| ChEBI_Ref = {{ebicite|changed|EBI}} 
| ChEBI = 9711

<!--Chemical data-->
| C=18 | H=19 | F=3 | N=2 | S=1
| molecular_weight = 352.418 g/mol
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C18H19F3N2S/c1-22(2)10-5-11-23-14-6-3-4-7-16(14)24-17-9-8-13(12-15(17)23)18(19,20)21/h3-4,6-9,12H,5,10-11H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = XSCGXQMFQXDFCW-UHFFFAOYSA-N
| smiles = CN(C)CCCN1c2ccccc2Sc2ccc(cc12)C(F)(F)F
}}

'''Triflupromazine''' ('''Vesprin''') is an [[antipsychotic]] medication of the [[phenothiazine]] class. Among different effects of triflupromazine indication for use of this drug is severe [[emesis]]. Due to its potential side effects (triflupromazine has higher risk for side effects than many other antipsychotics) it is not gold standard in antiemetic therapy.

Serious side effects of triflupromazine can be [[akathisia]] and [[tardive dyskinesia]] as well as the rare, but potentially fatal, [[neuroleptic malignant syndrome]].

==References==
{{Reflist|2}}


{{Antipsychotics}}
{{Navboxes
| title = [[Pharmacodynamics]]
| titlestyle = background:#ccccff
| list1 = 
{{Adrenergic receptor modulators}}
{{Dopamine receptor modulators}}
{{Histamine receptor modulators}}
{{Muscarinic acetylcholine receptor modulators}}
{{Serotonin receptor modulators}}
}}
{{Tricyclics}}

[[Category:Dopamine antagonists]]
[[Category:Phenothiazines]]
[[Category:Trifluoromethyl compounds]]
[[Category:Typical antipsychotics]]


{{Nervous-system-drug-stub}}